News & Updates

Show Multimedia Only

Product Highlight - Lantus

Product Highlight - Lantus

Insulin Glargine 100 units/mL vial

Product Highlight - Lantus

Product Highlight - ZYMOCORT

Product Highlight - ZYMOCORT

Mometasone furoate nasal spray 50 mcg/actuation

Product Highlight - ZYMOCORT

Product Highlight - CEFUDYNE

Product Highlight - CEFUDYNE

Cefuroxime axetil 250 mg/5 mL Powd for oral susp

Product Highlight - CEFUDYNE

Product Highlight - SALINASE

Product Highlight - SALINASE

NaCl 0.65% nasal drops

Product Highlight - SALINASE

Product Highlight - AZITHRODYN

Product Highlight - AZITHRODYN

Azithromycin 500 mg FC tab

Product Highlight - AZITHRODYN

Product Highlight - SALINASE MAX

Product Highlight - SALINASE MAX

NaCl 0.65%, xylitol 2.5% (isotonic, buffered soln) nasal drops

Product Highlight - SALINASE MAX

Product Highlight - CARIVALAN

Product Highlight - CARIVALAN

Carvedilol + Ivabradine HCl 6.25 mg/5 mg, 12.5 mg/5 mg, 25 mg/5 mg FC tab

Product Highlight - CARIVALAN

Product Highlight - DYMETRAZOLE

Product Highlight - DYMETRAZOLE

Metronidazole 500 mg tab

Product Highlight - DYMETRAZOLE

Product Highlight - ZINBEE

Product Highlight - ZINBEE

Zinc gluconate 70 mg chewable tab, 70 mg/5 mL syr

Product Highlight - ZINBEE

Investigational nasal spray for dry eye disease scores high in phase II trial

Investigational nasal spray for dry eye disease scores high in phase II trial

The single-dose nicotinic acetylcholine receptor agonist OC-02, administered as an aqueous nasal spray, helps increase tear production and improve eye dryness in patients with dry eye disease (DED), according to data from the phase II PEARL trial.

Investigational nasal spray for dry eye disease scores high in phase II trial

16 Aug 2022

Something went wrong.